IRIS
GOZZO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.501
AS - Asia 1.207
EU - Europa 569
SA - Sud America 158
AF - Africa 142
OC - Oceania 6
Totale 3.583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.475
CN - Cina 539
SG - Singapore 455
IT - Italia 259
IE - Irlanda 163
KR - Corea 149
BR - Brasile 146
CI - Costa d'Avorio 79
SN - Senegal 39
FI - Finlandia 25
NL - Olanda 24
IN - India 22
CA - Canada 17
SE - Svezia 16
GB - Regno Unito 14
DE - Germania 12
UA - Ucraina 12
VN - Vietnam 11
BE - Belgio 10
NG - Nigeria 8
ZA - Sudafrica 8
BD - Bangladesh 7
RU - Federazione Russa 7
AU - Australia 6
ES - Italia 6
MX - Messico 6
PL - Polonia 6
JP - Giappone 5
TR - Turchia 5
AR - Argentina 4
AT - Austria 3
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
KE - Kenya 2
KZ - Kazakistan 2
NO - Norvegia 2
OM - Oman 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
DZ - Algeria 1
EG - Egitto 1
FR - Francia 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
IS - Islanda 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MW - Malawi 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 3.583
Salva come PNG Salva come JPEG
Città #
Santa Clara 382
Dallas 342
Hefei 311
Singapore 282
Dublin 162
Seoul 149
Ashburn 102
Chicago 85
Boardman 80
Abidjan 79
Chandler 64
Beijing 42
Civitanova Marche 39
Dakar 39
Los Angeles 35
Catania 32
Rome 27
Washington 19
Amsterdam 18
Stockholm 16
New York 14
Lappeenranta 11
Palermo 11
Pune 11
São Paulo 11
Brussels 10
Milan 10
Campobasso 9
Abuja 8
Montreal 8
Phoenix 8
Seattle 8
Cambridge 7
Council Bluffs 7
Helsinki 7
Lawrence 7
Rio de Janeiro 7
Andover 6
Brooklyn 6
Warsaw 6
Boston 5
Des Moines 5
Jacksonville 5
Johannesburg 5
Munich 5
Tokyo 5
Assago 4
Assoro 4
Augusta 4
Bologna 4
Chennai 4
Dong Ket 4
Gela 4
Melbourne 4
Reggio Calabria 4
Trento 4
Turku 4
Anápolis 3
Belo Horizonte 3
Castelraimondo 3
Columbus 3
Espoo 3
Florence 3
Lamezia Terme 3
Manchester 3
Messina 3
Piazzola Sul Brenta 3
Poplar 3
Querétaro 3
Redondo Beach 3
San Francisco 3
San Giovanni la Punta 3
Secaucus 3
Shenyang 3
The Dalles 3
Adamantina 2
Agawam 2
Atlanta 2
Bari 2
Betim 2
Brasília 2
Cabo Frio 2
Caruaru 2
Caxias do Sul 2
Cernusco sul Naviglio 2
Charlotte 2
Coimbatore 2
Curitiba 2
Formia 2
Franca 2
Guangzhou 2
Guarulhos 2
Haiphong 2
Hanoi 2
Hebei 2
Hengyang 2
Hong Kong 2
Itaquaquecetuba 2
Las Vegas 2
London 2
Totale 2.655
Salva come PNG Salva come JPEG
Nome #
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 123
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 113
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure 101
Fluoxetine Protects Retinal Ischemic Damage in Mice 96
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 95
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 92
Accesso ai medicinali innovativi per indicazioni neurologiche in Europa: allineamento delle valutazioni di Health Technology Assessment tra i Paesi Europei 90
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 89
Linking the Price of Cancer Drug Treatments to Their Clinical Value 81
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 80
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries 80
EMA: l’ente che vigila sui medicinali che circolano nella Comunità Europea 79
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation 78
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 78
Sviluppo ed uso dei farmaci: dal laboratorio alla clinica. 76
Editorial: Innovation in ocular pharmacology 71
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies 71
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries 70
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 70
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 68
Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries 68
COVID-19 Disease and Vitamin D: A Mini-Review 67
Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue 67
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 66
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) 65
Response to Letter to the Editor by Dr. Garattini 65
AIFA: l’ente che autorizza un nuovo farmaco, una nuova formulazione o una nuova indicazione in Italia 64
Bioequivalence, Drugs with Narrow Therapeutic Index and The Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution 63
Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap 62
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? 62
Attitude survey of spontaneous adverse drug-reaction reporting by general practitioners in Sicily 59
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved? 57
OFF-LABEL USE OF MEDICINES: A CLINICAL AND REGULATORY OPPORTUNITYTHE. 40TH CONGRESS OF THE ITALIAN PHARMACOLOGICAL SOCIETY (SIF) 55
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence 54
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of Action 53
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) 53
Periodontal Disease and Pregnancy: Correlation with Underweight Birth 53
Beyond the budget silo approach: estimating health system sustainability for future dementia drugs 52
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 51
Editorial: Innovative treatments for neuro-psychiatric diseases 51
Anemia Mediterranea o talassemia: c’è qualcosa per evitare le trasfusioni? 49
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2019. Roma: Agenzia Italiana del Farmaco, 2020. 48
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience 47
La sclerosi multipla: una malattia invalidante con nuove possibilità di cura 47
Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation 47
Obesità e farmaci: quando servono e quali usare 46
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries 46
Starting Dose Of Non-Vitamin K Antagonist Oral Anticoagulation Agents In Patients With Atrial Fibrillation: Data From Italian Monitoring Registries 46
Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA 45
Scheda informativa Tocilizumab per uso endovenoso nel trattamento di pazienti gravi con COVID-19 44
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review 44
SARS-Cov-2 Damage on the Nervous System and Mental Health 44
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota 43
Prevenzione e terapia dell’osteoporosi: quali farmaci sono utili e cosa c’è di nuovo 40
Quali farmaci usare per l’età pediatrica? 40
Più che una speranza, oggi è una certezza la possibilità di ridurre la gravità dell’atrofia muscolare spinale 40
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2018. Roma: Agenzia Italiana del Farmaco, 2019 37
Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study) 36
Asma: vecchi e nuovi farmaci e attenzione al CoViD-19 25
Totale 3.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 3 0 1 0 1 3 3 5
2021/202275 1 6 3 1 8 5 6 1 10 10 5 19
2022/2023500 8 11 4 10 80 99 31 102 118 1 24 12
2023/2024448 18 58 35 42 26 97 21 39 3 13 62 34
2024/20251.404 19 161 62 64 312 162 71 40 91 110 135 177
2025/20261.240 256 396 409 179 0 0 0 0 0 0 0 0
Totale 3.702